Health Care & Life Sciences » Pharmaceuticals | Samil Pharmaceutical Co. Ltd.

Samil Pharmaceutical Co. Ltd.

Samil Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW1166.61
Market Cap
KRW164.49 B
Shares Outstanding
6.5 M
Public Float
3.59 M

Profile

Address
155 Hyoryeong-ro
Seoul SL 06666
Korea, Republic Of
Employees -
Website http://www.samil-pharm.com
Updated 07/08/2019
Samil Pharmaceutical Co., Ltd. engages in the development and manufacture of pharmaceutical products. Its products include CNS Drugs, Ophthalmic Drugs, Respiratory Drugs, Genito-urinary Drugs, Antibiotics Chemotherapeutics, Circulatory Drugs, Gastro-Intestinal Drugs, Agents for Diabetes Mellitus, Hormones, Metabolic Drugs, Disinfectants, Amino Acids, Dental Preparations, Antipyretic, Allergy Drugs, Antihistamines, Analgesic and Anti-inflammatory Agents. The company was founded on October 7, 1947 and is headquartered in Seoul, South Korea.

Financials

View All
Created with Highcharts 5.0.14Samil Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.7 9307 93011 19011 1905885888878871 2671 2678 5638 56320132014201520162017201802.5k5k7.5k10k12.5k
Created with Highcharts 5.0.14Samil Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.89 22989 22985 46185 46188 13688 13696 75896 75892 03892 03894 60094 600201320142015201620172018025k50k75k100k125k

Kang Huh
Chairman & Co-Chief Executive Officer
Chang-Jin Song
Outside Director